Patent · US Active

Benzimidazole derivatives and use thereof as IDH1 inhibitors

US11407717B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

KPC PHARMACEUTICALS, INC · CN

Inventors

Dahai Wang · Shanghai, CN
Wenyuan Qian · Newbury Park, US
Shilan Liu · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Jun 26, 2019
Grant date	Aug 9, 2022
Priority date	—
Expiry date	Jun 26, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D235/30
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to benzimidazole compounds and an application thereof as IDH1 mutant inhibitors, in particular, to a compound as represented by formula (I), tautomers thereof, or pharmaceutically acceptable salts thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.